Tocagen to Present at Upcoming Jefferies 2019 Healthcare Conference
SAN DIEGO, May 30, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced Marty Duvall, chief executive officer, will present at the Jefferies 2019 Healthcare Conference on Thursday, June 6, at 4:00 p.m. ET in New York City. The live audio webcast from the conference and subsequent replay may be accessed by visiting Tocagen's website. The webcast will be available shortly after conclusion of the presentation and archived on the company's website for 30 days following the presentation. About Tocagen Tocagen Media Contact: Tocagen Investor Contact: View original content to download multimedia:http://www.prnewswire.com/news-releases/tocagen-to-present-at-upcoming-jefferies-2019-healthcare-conference-300858840.html SOURCE Tocagen Inc. |
|